Alcon reviews

The continued transition as a division of Novartis - and the voluntary and involuntary flight of talent - has put this company on a slow decline. Morale and employee engagement suffered significantly during the extended Novartis acquisition, and the integration process has been painful. Far too often, the directions out of Basel are form over substance, focusing on adhering to the required standard process rather than assessing applicability and impact. Work/life balance is elusive here. Far too much work allocated to far to few employees. IT systems are incapable of meeting Novartis demands and timetables. As a result, often work is done outside systems, then later forced in manually.

Management - senior and middle - thinks they can treat employees as they wish since company offers good benefits. Management proudly mentions this to their employees. Management approach is 'management by fear'. People who know someone higher up, are safe in this company however incompetent they are. Groupism (& you scratch my back, I will scratch yours) is rampant.